Clinical Trial: A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07048197) titled 'A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease' on June 24.

Brief Summary: A study to assess safety, cellular kinetics and exploratory efficacy of rapcabtagene autoleucel in rheumatoid arthritis and Sjogren's disease

Study Start Date: June 20

Study Type: INTERVENTIONAL

Condition: Difficult-to-treat Rheumatoid Arthritis (RA) and Severe, Refractory Sjogren's Disease (SjD)

Intervention: BIOLOGICAL: Rapcabtagene autoleucel

Single infusion of Rapcabtagene autoleucel

Recruitment Status: RECRUITING

Sponsor: Novartis Pharmaceuticals

Publi...